BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12

• Press Releases

  Spyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa

  August 10, 2026

   · 

  5 min read
• Press Releases

  Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results

  August 10, 2026

   · 

  12 min read
• Press Releases

  Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval

  August 10, 2026

   · 

  16 min read
• Press Releases

  Novo Nordisk and AWS enter strategic partnership to accelerate drug discovery through AI

  August 10, 2026

   · 

  3 min read
• Press Releases

  CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

  August 10, 2026

   · 

  14 min read
• Press Releases

  Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance

  August 10, 2026

   · 

  19 min read
• Press Releases

  Eikon Therapeutics Appoints Johnny Bennett, Ph.D. to its Scientific Advisory Board

  August 10, 2026

   · 

  6 min read
• Press Releases

  Orion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint

  August 10, 2026

   · 

  2 min read
• Press Releases

  Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

  August 10, 2026

   · 

  10 min read
• Press Releases

  Curium acquires Abscint SA, expanding PET radiodiagnostic pipeline in oncology

  August 10, 2026

   · 

  4 min read